Skip Ribbon Commands
Skip to main content

​​​​​​​​​​​​​​​​​

​​

Photo of the WATCHMAN ImplantThe Heart Hospital Baylor Plano Becomes Official Implant Center for WATCHMAN™ Device​ ​

The Heart Hospital Baylor Plano is among the first hospitals in Dallas-Fort Worth to offer patients with non-valvular atrial fibrillation (AF) an alternative to long-term warfarin medication with the newly approved WATCHMAN Left Atrial Appendage Closure (LAAC) Implant

February 16, 2017 - ​For patients with AF who are considered suitable for warfarin by their physicians but who have reason to seek a non-drug alternative, the WATCHMAN LAAC Implant is an implant alternative to reduce their risk of AF-related stroke. The WATCHMAN​ Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin. Read the full article »


Illustration of the St. Jude Medical EnSite Precision​The Heart Hospital Baylor Plano is First in North Texas to Utilize Next Generation Cardiac Mapping System

New technology gives detailed look inside the heart for treatment of irregular heartbeat

February 10, 2017 - The Heart Hospital Baylor Plano is the first North Texas hospital to use the St. Jude Medical™ EnSite Precision™ cardiac mapping system, a next generation technology that helps physicians diagnose arrhythmias, or irregular heartbeats, and determine the best treatment options. Read the full article ​»

Image courtesy of: St. Jude Medical™ EnSite Precision™


The Heart Hospital Baylor Plano Performs First Robotic-Assisted Angioplasty in DFW

​Patients with coronary artery disease can now be treated with new robotic-assisted technology

January 19, 2017 – The Heart Hospital Baylor Plano today announced the successful completion of the first robotic-assisted coronary angioplasty in the Dallas/Fort Worth region. The procedure has been performed using Corindus Vascular Robotics CorPath System—the first and only FDA-cleared medical device to bring robotic-assisted precision to coronary angioplasty procedures. Read the full article »​​

CARDIOVASCULAR IQ